The study’s findings demonstrated that FMT restored the bacteria’s abundance in CRC mice to levels comparable to those in control mice, perhaps assisting in the downregulation of BIRC5 expression in cancer treatment-related scenarios. This evidence concerns the gene BIRC5 and colorectal carcinoma.